Fausto Meriggi

1.1k total citations · 1 hit paper
63 papers, 641 citations indexed

About

Fausto Meriggi is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Pathology and Forensic Medicine. According to data from OpenAlex, Fausto Meriggi has authored 63 papers receiving a total of 641 indexed citations (citations by other indexed papers that have themselves been cited), including 51 papers in Oncology, 25 papers in Pulmonary and Respiratory Medicine and 8 papers in Pathology and Forensic Medicine. Recurrent topics in Fausto Meriggi's work include Colorectal Cancer Treatments and Studies (24 papers), Cancer Treatment and Pharmacology (20 papers) and Lung Cancer Treatments and Mutations (13 papers). Fausto Meriggi is often cited by papers focused on Colorectal Cancer Treatments and Studies (24 papers), Cancer Treatment and Pharmacology (20 papers) and Lung Cancer Treatments and Mutations (13 papers). Fausto Meriggi collaborates with scholars based in Italy, United States and Spain. Fausto Meriggi's co-authors include Alberto Zaniboni, Anna Rizzi, Chiara Cremolini, Chiara Abeni, Qui Tran, Joseph Chao, D. Páez López-Bravo, Taito Esaki, Filippo Pietrantonio and Marwan Fakih and has published in prestigious journals such as New England Journal of Medicine, Journal of Clinical Oncology and The Lancet Oncology.

In The Last Decade

Fausto Meriggi

63 papers receiving 627 citations

Hit Papers

Sotorasib plus Panitumumab in Refractory Colorectal Cance... 2023 2026 2024 2025 2023 50 100 150
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Sotorasib plus Panitumumab in Refractory Colorectal Cancer with Mutated KRAS G12C
    2023 163 citations Marwan Fakih, Lisa Salvatore et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Fausto Meriggi Italy 14 415 195 144 92 88 63 641
K C Lakshmaiah India 11 315 0.8× 186 1.0× 105 0.7× 92 1.0× 72 0.8× 28 544
Leïla Bengrine-Lefèvre France 15 573 1.4× 151 0.8× 103 0.7× 64 0.7× 73 0.8× 45 806
N. W. Peacock United States 14 512 1.2× 237 1.2× 168 1.2× 60 0.7× 127 1.4× 42 871
Capucine Baldini France 16 686 1.7× 280 1.4× 140 1.0× 54 0.6× 103 1.2× 89 964
Mustafa Oktay Tarhan Türkiye 18 612 1.5× 228 1.2× 117 0.8× 52 0.6× 180 2.0× 63 867
Aytuğ Üner Türkiye 15 400 1.0× 189 1.0× 131 0.9× 56 0.6× 105 1.2× 70 786
Chee Kian Tham Singapore 16 252 0.6× 146 0.7× 138 1.0× 79 0.9× 97 1.1× 40 653
George Zarkavelis Greece 15 458 1.1× 170 0.9× 169 1.2× 157 1.7× 158 1.8× 52 813
Vittorio Franciosi Italy 17 533 1.3× 470 2.4× 160 1.1× 84 0.9× 131 1.5× 37 809
Olivier Capitain France 15 535 1.3× 269 1.4× 115 0.8× 76 0.8× 47 0.5× 59 826

Countries citing papers authored by Fausto Meriggi

Since Specialization
Citations

This map shows the geographic impact of Fausto Meriggi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fausto Meriggi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fausto Meriggi more than expected).

Fields of papers citing papers by Fausto Meriggi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fausto Meriggi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fausto Meriggi. The network helps show where Fausto Meriggi may publish in the future.

Co-authorship network of co-authors of Fausto Meriggi

This figure shows the co-authorship network connecting the top 25 collaborators of Fausto Meriggi. A scholar is included among the top collaborators of Fausto Meriggi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fausto Meriggi. Fausto Meriggi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Pietrantonio, Filippo, Lisa Salvatore, Taito Esaki, et al.. (2025). Overall Survival Analysis of the Phase III CodeBreaK 300 Study of Sotorasib Plus Panitumumab Versus Investigator's Choice in Chemorefractory KRAS G12C Colorectal Cancer. Journal of Clinical Oncology. 43(19). 2147–2154. 7 indexed citations
2.
Libertini, Michela, et al.. (2025). What Is Next for Refractory Colorectal Cancer CRC? Looking Beyond SUNLIGHT, FRESCO2, RECURSE and CORRECT. International Journal of Molecular Sciences. 26(6). 2522–2522. 1 indexed citations
3.
Libertini, Michela, et al.. (2025). Training gut and body: physical activity, diet, ASA and microbiota influence the outcome in gastrointestinal cancer survivors. Frontiers in Nutrition. 12. 1648004–1648004. 1 indexed citations
4.
5.
Meriggi, Fausto. (2024). Second-Line Treatment Options for Small-Cell Lung Cancer: A Light at the End of the Tunnel. Cancers. 16(2). 255–255. 6 indexed citations
6.
Meriggi, Fausto, et al.. (2023). Low-Dose Immunotherapy: Is It Just an Illusion?. Biomedicines. 11(4). 1032–1032. 6 indexed citations
7.
8.
Meriggi, Fausto. (2021). Controversial link between proton pump inhibitors and anticancer agents: review of the literature. Tumori Journal. 108(3). 204–212. 6 indexed citations
9.
Meriggi, Fausto & Alberto Zaniboni. (2020). Antibiotics and steroids, the double enemies of anticancer immunotherapy: a review of the literature. Cancer Immunology Immunotherapy. 70(6). 1511–1517. 15 indexed citations
10.
Passalacqua, Rodolfo, Giuseppe Maglietta, Margherita Ratti, et al.. (2020). 1697P Cancer patients’ perceptions, opinions and feelings during the COVID-19 epidemic in the most affected Italian areas: Serial cross-sectional study. Annals of Oncology. 31. S1001–S1002. 2 indexed citations
11.
Meriggi, Fausto, Claudio Codignola, Tiziana Prochilo, et al.. (2019). Yoga Protocol for Cancer Patients: A Systematic Exploration of Psychophysiological Benefits. Reviews on Recent Clinical Trials. 14(4). 261–268. 1 indexed citations
12.
Demurtas, Laura, Marco Puzzoni, Riccardo Giampieri, et al.. (2017). The role of primary tumour sidedness, EGFR gene copy number and EGFR promoter methylation in RAS/BRAF wild-type colorectal cancer patients receiving irinotecan/cetuximab. British Journal of Cancer. 117(3). 315–321. 18 indexed citations
13.
Prochilo, Tiziana, Francesca Aroldi, Paola Bertocchi, et al.. (2014). Blind Snipers: Relevant Off Target Effects of Non-chemotherapeutic Agents in Oncology: Review of the Literature. Reviews on Recent Clinical Trials. 9(2). 102–114. 3 indexed citations
14.
Aroldi, Francesca, Paola Bertocchi, Fausto Meriggi, et al.. (2014). Tyrosine Kinase Inhibitors in EGFR-Mutated Large-Cell Neuroendocrine Carcinoma of the Lung A Case Report. Case Reports in Oncology. 7(2). 478–483. 22 indexed citations
15.
Meriggi, Fausto, et al.. (2008). The Renaissance of Platinum-Based Chemotherapy for Metastatic Breast Cancer. Journal of Chemotherapy. 20(5). 551–560. 4 indexed citations
16.
Meriggi, Fausto & Alberto Zaniboni. (2005). Non-small-cell lung cancer in the elderly. Critical Reviews in Oncology/Hematology. 57(2). 183–190. 8 indexed citations
17.
Zaniboni, Alberto, Andrea Ardizzoni, Filippo de Marinis, et al.. (2003). Phase II Study of Taxol Combined With Ifosfamide and Carboplatin in the Treatment of Stage IIIb–IV Non-Small-Cell Lung Cancer. American Journal of Clinical Oncology. 26(1). 84–88. 6 indexed citations
18.
Zaniboni, Alberto, et al.. (1993). L-folinic acid and 5-fluorouracil in the treatment of advanced breast cancer: A phase II study. Annals of Oncology. 4. S41–S43. 17 indexed citations
19.
Arcangeli, Giuseppina, Alberto Zaniboni, Salvatore Milano, et al.. (1993). MICE: a new active combination for non-small cell lung cancer. European Journal of Cancer. 29(13). 1848–1850. 6 indexed citations
20.
Zaniboni, Alberto, et al.. (1991). Fluorouracil, High-Dose Folinic Acid, Low-Dose α-2b Interferon and Dipyridamole in the Treatment of Advanced Colorectal Cancer. A Pilot Study. Journal of Chemotherapy. 3(3). 180–182. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by K C Lakshmaiah Breakdown of academic impact, for papers by Leïla Bengrine-Lefèvre Breakdown of academic impact, for papers by N. W. Peacock Breakdown of academic impact, for papers by Capucine Baldini Breakdown of academic impact, for papers by Mustafa Oktay Tarhan Breakdown of academic impact, for papers by Aytuğ Üner Breakdown of academic impact, for papers by Chee Kian Tham Breakdown of academic impact, for papers by George Zarkavelis Breakdown of academic impact, for papers by Vittorio Franciosi Breakdown of academic impact, for papers by Olivier Capitain
Rankless by CCL
2026